David Cunningham
Impact in
- Oncology top 0.01%
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Pathology and Forensic Medicine top 0.01%
- Lymphoma Diagnosis and Treatment
- Genetic factors in colorectal cancer
Papers in
- Oncology 548
- Colorectal Cancer Treatments and Studies 283
- Pancreatic and Hepatic Oncology Research 92
- Colorectal Cancer Surgical Treatments 80
- Cancer Treatment and Pharmacology 70
-
- Lymphoma Diagnosis and Treatment 153
- Co-authors
- Ian Chau (185 shared papers)Timothy J. Iveson (29 shared papers)William Allum (36 shared papers)Eric Van Cutsem (42 shared papers)Elizabeth Catherine Smyth (48 shared papers)Andrew Richard Norman (60 shared papers)Naureen Starling (93 shared papers)Marianne C. Nicolson (21 shared papers)
- Journals
- Annals of Oncology (148 papers)British Journal of Cancer (82 papers)Journal of Clinical Oncology (74 papers)European Journal of Cancer (72 papers)Blood (33 papers)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
David Cunningham
1.2k papers receiving 99.0k citations
David Cunningham's Hit Papers
Peers
Comparison fields: 5 of 199
- Oncology 45.2k
- Pathology and Forensic Medicine 15.1k
- Pulmonary and Respiratory Medicine 25.6k
- Hepatology 5.7k
- Gastroenterology 4.0k
Countries citing papers authored by David Cunningham
This map shows the geographic impact of David Cunningham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Cunningham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Cunningham more than expected).
Fields of papers citing papers by David Cunningham
This network shows the impact of papers produced by David Cunningham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Cunningham. The network helps show where David Cunningham may publish in the future.
Co-authors
The 25 scholars most cited alongside David Cunningham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 1.2k papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer Hit paper breakdown → | 2006 | 5018 |
| 2 | Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer Hit paper breakdown → | 2004 | 4215 |
| 3 | Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer Hit paper breakdown → | 2010 | 3469 |
| 4 | Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial Hit paper breakdown → | 2000 | 2733 |
| 5 | Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial Hit paper breakdown → | 2014 | 1964 |
| 6 | Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer Hit paper breakdown → | 2008 | 1901 |
| 7 | Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer Hit paper breakdown → | 2013 | 1858 |
| 8 | Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status Hit paper breakdown → | 2011 | 1595 |
| 9 | Patient-derived organoids model treatment response of metastatic gastrointestinal cancers Hit paper breakdown → | 2018 | 1589 |
| 10 | Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial Hit paper breakdown → | 2017 | 1516 |
| 11 | Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study Hit paper breakdown → | 2010 | 1497 |
| 12 | A Prognostic Score for Advanced Hodgkin's Disease Hit paper breakdown → | 1998 | 1403 |
| 13 | Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Hit paper breakdown → | 2016 | 1224 |
| 14 | Colorectal cancer Hit paper breakdown → | 2010 | 1209 |
| 15 | Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Hit paper breakdown → | 2010 | 1189 |
| 16 | The role of probiotics in aquaculture Hit paper breakdown → | 2006 | 1131 |
| 17 | Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection Hit paper breakdown → | 2010 | 1105 |
| 18 | Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer Hit paper breakdown → | 1998 | 1069 |
| 19 | Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial Hit paper breakdown → | 2009 | 989 |
| 20 | Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial Hit paper breakdown → | 2015 | 943 |
About David Cunningham
David Cunningham is a scholar working on Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Surgery and Genetics, having authored 1.2k papers that have together received 102.5k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (283 papers), Gastric Cancer Management and Outcomes (201 papers), Lymphoma Diagnosis and Treatment (153 papers), Esophageal Cancer Research and Treatment (93 papers), Pancreatic and Hepatic Oncology Research (92 papers), Colorectal Cancer Surgical Treatments (80 papers), Colorectal and Anal Carcinomas (74 papers) and Cancer Treatment and Pharmacology (70 papers). The work is most often cited by research in Oncology (45.2k citations), Pathology and Forensic Medicine (15.1k citations), Pulmonary and Respiratory Medicine (25.6k citations), Hepatology (5.7k citations) and Gastroenterology (4.0k citations). David Cunningham has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Ian Chau, Timothy J. Iveson, William Allum, Eric Van Cutsem, Elizabeth Catherine Smyth, Andrew Richard Norman, Naureen Starling, Marianne C. Nicolson, Alicia F. C. Okines and Andrés Cervantes. Their work appears in journals such as Annals of Oncology, British Journal of Cancer, Journal of Clinical Oncology, European Journal of Cancer and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.